| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Service de Médecine Interne et Laboratoire d'Investigation Clinique [J. C. H., N. L.] and Service d'Anatomie Pathologique [R. H.], Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet,2, 1000 Brussels, Belgium
Administration of insulin for 6 weeks at a daily dose of 2.5 i.u./100 g body weight, together with a 10% glucose solution as drinking fluid, increased tumor growth 8.3-fold as compared with a matched, untreated control group. Administration of insulin alone or of a 10% glucose solution alone produced a smaller yet statistically significant increase (4.8- and 2.2-fold, respectively). In oophorectomized rats, administration of the same dose of insulin, together with the 10% glucose solution for 4 weeks, failed to prevent tumor regression resulting from oophorectomy. On the other hand, in hypophysectomized rats, administration of insulin for 3 weeks at a daily dose of 0.4 to 0.8 i.u./100 g body weight significantly reactivated tumor growth, as compared with a matched control group, when started 21 days after hypophysectomy. Both insulin-treated and control groups received, in addition, a 10% glucose solution and daily s.c. injections of 1.5 mg ovine prolactin; the latter proved by itself incapable of significantly reactivating tumor growth.
It is concluded that insulin administered in vivo appears to display intrinsic growth-stimulating properties on the mammary tumor tissue, similar to those previously demonstrated in organ culture. The present study, complementing earlier investigations in alloxan-diabetic rats, provides further evidence suggesting that the rat mammary carcinoma, in addition to being estrogen and prolactin dependent, is also insulin dependent.
1 This work was supported by a grant from the Fonds Cancérologique de la Caisse Générale d'Epargne et de Retraite. This is paper 2 of a series of 2. The 1st paper (12) appears in this issue.
2 This service is affiliated with the European Organization for Research on Treatment of Cancer (EORTC) and with the Association Euratom-University of Brussels-University of Pisa.
Received 7/16/71. Accepted 10/ 7/71.
This article has been cited by other articles:
![]() |
J. Chappell, J. W. Leitner, S. Solomon, I. Golovchenko, M. L. Goalstone, and B. Draznin Effect of Insulin on Cell Cycle Progression in MCF-7 Breast Cancer Cells. DIRECT AND POTENTIATING INFLUENCE J. Biol. Chem., October 5, 2001; 276(41): 38023 - 38028. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |